Financial results - OTOMED RESEARCH SRL

Financial Summary - Otomed Research Srl
Unique identification code: 36120814
Registration number: J40/7341/2016
Nace: 7219
Sales - Ron
41.760
Net Profit - Ron
3.086
Employee
1
The most important financial indicators for the company Otomed Research Srl - Unique Identification Number 36120814: sales in 2023 was 41.760 euro, registering a net profit of 3.086 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Otomed Research Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 7.873 15.820 17.076 34.749 28.668 27.276 36.819 41.760
Total Income - EUR - - 7.873 15.820 17.076 34.749 28.668 27.276 36.870 42.093
Total Expenses - EUR - - 11.610 29.361 28.282 27.191 25.342 25.353 34.786 38.450
Gross Profit/Loss - EUR - - -3.737 -13.541 -11.205 7.559 3.326 1.922 2.084 3.643
Net Profit/Loss - EUR - - -3.895 -13.883 -11.376 6.516 2.495 1.104 978 3.086
Employees - - 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 13.8%, from 36.819 euro in the year 2022, to 41.760 euro in 2023. The Net Profit increased by 2.111 euro, from 978 euro in 2022, to 3.086 in the last year.

Check the financial reports for the company - Otomed Research Srl

Rating financiar

Financial Rating -
Otomed Research Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Otomed Research Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Otomed Research Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Otomed Research Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Otomed Research Srl - CUI 36120814

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 0 0 0 0 0 0 0
Current Assets - - 941 1.427 1.578 8.285 11.289 16.044 22.196 20.867
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 493 322 0 5.729 10.647 15.740 17.122
Cash - - 941 934 1.256 8.285 5.560 5.396 6.456 3.745
Shareholders Funds - - -3.850 -17.668 -11.217 -4.483 -1.901 -755 221 3.306
Social Capital - - 45 44 9.670 9.483 9.305 9.099 9.127 9.099
Debts - - 5.797 19.293 12.846 12.824 13.339 16.961 22.117 17.712
Income in Advance - - 804 814 950 957 957 951 953 954
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7219 - 7219"
CAEN Financial Year 7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 20.867 euro in 2023 which includes Inventories of 0 euro, Receivables of 17.122 euro and cash availability of 3.745 euro.
The company's Equity was valued at 3.306 euro, while total Liabilities amounted to 17.712 euro. Equity increased by 3.086 euro, from 221 euro in 2022, to 3.306 in 2023. The Debt Ratio was 80.6% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Otomed Research Srl

Comments - Otomed Research Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.